Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 28Terminated 10Withdrawn 2Unknown 2Recruiting 2

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 183Breast Neoplasms 174Carcinoma, Non-Small-Cell Lung 173Colorectal Neoplasms 105Stomach Neoplasms 81Pancreatic Neoplasms 79Lung Neoplasms 79Prostatic Neoplasms 77Melanoma 68Neoplasm Metastasis 67Recurrence 66Leukemia, Myeloid, Acute 66Multiple Myeloma 64Ovarian Neoplasms 62Carcinoma, Hepatocellular 62Lymphoma 61Advanced Solid Tumor 61Advanced Solid Tumors 56Solid Tumor 50Uterine Cervical Neoplasms 48Lymphoma, Non-Hodgkin 48Glioblastoma 44Lymphoma, B-Cell 40Leukemia 39Colonic Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Head and Neck Neoplasms 33Esophageal Neoplasms 32Urinary Bladder Neoplasms 30Sarcoma 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × Menorrhagia × Clear all
NCT05620355 2023-03-21

Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids.

Bio Genuine (Shanghai) Biotech Co., Ltd.

Phase 3 Unknown
312 enrolled

Leiomyoma, Menorrhagia

NCT03219385 2018-03-21

DIANA

Mirabilis Medica, Inc.

Phase NA Unknown
180 enrolled

Leiomyoma, Menorrhagia, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡